Ignite Creation Date:
2024-07-17 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 3:34 PM
Study NCT ID:
NCT06497465
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-07-12
First Post:
2024-07-04
Brief Title:
DolutegravirLamivudine Dual Therapy for ART-naïve People With HIV and TB Receiving Rifampin-based TB Treatment
Sponsor:
Johns Hopkins University
Organization:
Johns Hopkins University
Organization Data
Organization:
Johns Hopkins University
Class:
OTHER
Study ID:
IRB00441778
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Johns Hopkins University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| ViiV Healthcare | INDUSTRY |